SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

 Division of Infectious Diseases

[Return To Index page]
photo Tatiana Bogdanovich, MD, PhD, MSc

Director, Fecal Microbiota Transplant Program

Email: bogdanovicht@upmc.edu

Phone: 412-647-7228

Contact
Office: Falk Medical Building
3601 Fifth Ave, 7th Floor
Pittsburgh, PA 15213
 
Phone: 412-647-7228
Fax: 412-647-7951
E-mail: bogdanovicht@upmc.edu
Administrative Assistant:
Tanya Gonzales
Address: S869, Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261
Email: tal67@pitt.edu
Phone: 412-648-8510
Fax: 412-648-8455
Education and Training
Education
MD, Smolensk State Medical Academy, 1999
PhD, Smolensk State Medical Academy, 2003
MSc, University of London, 1999
Training
Residency Training, Internal Medicine, Pinnacle Health, Harrisburg, PA, 2009
Infectious Diseases Fellow, University of Pittsburgh Medical Center, 2011
Research Interest
Dr. Bogdanovich’s research interests are focused on the prevention and treatment of infections in solid organ transplant recipients, Colstridium difficile infection, and fecal microbiota transplantation (FMT). Over the last year, she has primarily focused on development of the Volunteer Stool Bank for FMT and development of FMT protocols including freeze-dried FMT capsules.
Clinical Interest
Dr Bogdanovich's primary clinical interest is in the area of infections in solid organ transplant recipients including bacterial, viral and fungal infections. As a member of the dedicated Transplant ID (TID) Group at the UPMC Presbyterian/Montefiore Hospitals, she sees patient both on the in-patient TID services and in the TID Clinic.

Her more recent clinical and research activities are focused on establishing the UPMC Fecal Microbiota Transplant program aimed at helping patients with recurrent and severe Clostridium difficile infections.
Publications
Selected Publications:
Silveira FP, R Abdel Massih, T Bogdanovich, DL Paktis, RL Routh, RB Moss. Treatment of resistant influenza virus infection in a hospitalized patient with cystic fibrosis with DAS181, a host-directed antiviral. Antivir. Ther. 2016; 21: 71-4.
Clancy CJ, EO Chen, RK Shields, Y Zhao, S Cheng, KD Chavda, B Hao, JH Hong, Y Doi, EJ Kwak, FP Silveira, R Abdel Massih, T Bogdanovich, A Humar, DS Perlin, BN Kreiswirth, NM Hong. Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant. 2013; 13: 2619-33.
Adams-Haduch J.M, EO Onuoha, T Bogdanovich, GB Tian, J Marschall, CM Urban, BJ Spellberg, D Rhee, DC Halstead, AW Pasculle, Y Doi. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. Microbiology. 2011; 49: 3849-54.
Bogdanovich T, JM Adams Haduch, GB Tian, MH Nguyen, EJ Kwak, CA Muto, Y Doi. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin. Infect. Disease. 2011; 53: 373-6.
Tian GB, Jm Adams Haduch, T Bogdanovich, HN Wang, Y Doi. PME-1, an Extended-spectrum ?-lactamase identified in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011; 55: 2710-3.